Motivation: Drug intercalation is an important strategy for DNA inhibition which is often employed in cancer chemotherapy. Despite its high significance, the field is characterized by limited success in identification of novel intercalator molecules and lack of automated and dedicated drug-DNA intercalation methodology. Results: We report here a novel intercalation methodology (christened 'Intercalate') for predicting both the structures and energetics of DNA-intercalator complexes, covering the processes of DNA unwinding and (non-covalent) binding. Given a DNA sequence and intercalation site information, Intercalate generates the 3D structure of DNA, creates the intercalation site, performs docking at the intercalation site and evaluates DNA-intercalator binding energy in an automated way. The structures and energetics of the DNA-intercalator complexes produced by Intercalate methodology are seen to be in good agreement with experiment. The dedicated attempt made in developing a drug-DNA intercalation methodology (compatible with its mechanism) with high accuracy should prove useful in the discovery of potential intercalators for their use as anticancers, antibacterials or antivirals.
Introduction
DNA plays a crucial role in a wide variety of cellular processes and acts as a superior target for treating hallmark genetic diseases like cancer (Hurley, 2002; Palchaudhuri and Hergenrother, 2007) . Blocking the disease-related pathway at an early stage would definitely be an effective means of shutting down the synthesis of offending proteins. A decent number of clinical intercalator molecules are available as anticancer, antiparasitic and antimicrobial agents (daunomycin, idarubicin, actinomycin D, epirubicin, quinacrine, ethidium bromide, proflavine, berberine, etc.) which exert their biological response via interaction with the double stranded DNA inhibiting the processes of transcription, replication and DNA repair mechanisms (Biebricher et al., 2015; Koster et al., 2007; Mukherjee and Sasikala, 2013; Tse and Boger, 2004; Wang et al., 1987) .
The two principal modes of small molecules interacting with DNA are through covalent and non-covalent binding (Waring, 1981) . Covalent binding is achieved by metallointercalators (the combination of organic and transition metal coordination compounds) which form novel interactions with DNA acting in dual-inhibition mode as-metal coordination and intercalation (e.g. cis-platin, [Pt(terpy)(HET)]þ) (Cepeda et al., 2007; Erkkila et al., 1999; Liu and Sadler, 2011) . On the contrary, groove binding and V C The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com intercalation are the predominant, reversible DNA binding modes of small molecules binding non-covalently. Minor groove binding molecules are typically crescent shaped, complementary to the shape of groove which promotes binding through van der Waals and hydrogen bonds (Baraldi et al., 2004; Neidle, 2001; Shaikh et al., 2004) . Most minor groove binding drugs bind to AT rich sequences (e.g. netropsin, distamycin, berenil) (Ren and Chaires, 1999) . A few major groove binders are also known (e.g. oligonucleotides) (Hamilton and Arya, 2012) . Minor groove binding is preferred over major as the deep and narrower groove provides molecules with a better/snug fit (Rohs et al., 2005) . Drug intercalation to DNA (where a planar moiety of an intercalator molecule inserts between the DNA adjacent bases) is a well-known process for interrupting DNA associated pathways (Hurley, 2002; Lerman, 1961) . To accommodate an intercalator, the DNA chain lengthens by decreasing the helical twist and unwinds slightly which in turn leads to local deformation of the DNA backbone. This alteration in structural and mechanical properties of DNA is highly undesirable for the biochemical pathways, and hence perturbing its normal function of RNA synthesis and replication, resulting in cell death (Berman and Young, 1981; Biebricher et al., 2015) . The reported drug-DNA intercalation mechanism sheds light on this process (Mukherjee et al., 2008) . Intercalating drugs typically but not necessarily, contain planar polyaromatic rings and cationic substituents (Sheng et al., 2013; Snyder et al., 2005) . The main driving force for intercalator binding is thought to be p interactions, others which contribute dominantly are van der Waals interactions and hydrophobic contributions (Chaires, 1997; Gago, 1998) . This study is focused on noncovalent DNA intercalators.
Two types of intercalator molecules excluding bis-intercalators are known as classic/mono-intercalators and threading intercalators (Fig. 1) . Proflavine is a simplified example of a classic intercalator (Neidle and Jones, 1975) . Nogalamycin belongs to a threading intercalator having flanking groups along the long axis of intercalating moiety which extends its DNA binding from intercalation to groove binding (major or minor) thus providing extra sequence specificity (Torigoe et al., 2002) . Further classification into parallel and perpendicular intercalators is also made based on the orientation of intercalating moiety with respect to the DNA base pairs. Again, proflavine and nogalamycin can be considered as examples of these intercalators.
CpG is the most preferred drug intercalation site as observed in maximum cases; a few additional sites identified are TpG and GpC (Boer et al., 2009; Sheng et al., 2013; Sun et al., 1989) . One of the novel drugs cryptolepine intercalates exceptionally at CpC site as revealed in a crystal structure with PDB 1K9G (Lisgarten et al., 2002) . The degree of unwinding of the DNA double helix at the intercalation site depends upon the intercalator. The unwinding is more with parallel intercalators compared to the perpendicular intercalators where no unwinding takes place, as unwinding increases the stacking interactions between the intercalating moiety and the DNA flanking base pairs (Williams et al., 1992) .
Although, DNA-as a drug target, has high therapeutic value, only a few softwares are available to perform DNA-ligand dockings compared to protein-ligand dockings such as GOLD (Jones et al., 1997) , GLIDE (Friesner et al., 2004) , DNA Ligand Docking (Jayaram et al., 2012; Shaikh and Jayaram, 2007) , AUTODOCK (Morris et al., 1998) , DOCK (Moustakas et al., 2006) and CDOCKER (Wu et al., 2003) . Not all of the aforementioned softwares are specifically parameterized to handle nucleic acids, particularly the DNA-intercalators. A few docking studies on DNA-intercalator systems are reported using AUTODOCK (Gilad and Senderowitz, 2014; Holt et al., 2008; Netz, 2012) , however, with DNA structures having preformed intercalation sites (i.e. by removing the ligand from the crystal complex). Structural databases are rather limited with the DNA-intercalator complexes, which further limits the scope of these studies to a few DNA structures/sequences.
We, therefore, report here a robust, state of the art computational protocol called Intercalate which can accurately create the 3D structure of DNA from the DNA sequence along with an intercalation site, dock a ligand at the intercalation site and predict the best binding mode of ligand efficiently through binding free energy estimations in an automated mode. It can handle both classic and threading intercalation modes. The methodology is made available as a free webserver at www.scfbio-iitd.res.in/intercalate with no login requirements.
Furthermore, we have also analyzed the energetics of binding of over 40 DNA-intercalator complexes utilizing AMBER modules and find that the intercalation process is driven predominantly by van der Waals and hydrophobic contributions. Enthalpy-entropy compensation plays a big role in drug-DNA intercalation process (Breslauer et al., 1987) .
Materials and methods
To initiate DNA-intercalator docking and scoring, one must have the 3D structure of DNA sequence of interest with preformed intercalation site and ligand as an intercalator. The RCSB/NDB database is limited for the range of DNA-intercalator complexes (Berman et al., 2000 (Berman et al., , 1992 . To fill this lacuna, we first discuss an algorithm to generate the 3D coordinates of DNA, unwinding and lengthening of the DNA and then creating an intercalation gap at the desired site which can further serve as input for docking.
2.1 Creation of DNA structure with an intercalation site(s)
The DNA with an intercalation site is created in the following three steps:
Step (i). This step involves the generation of a regular/standard BDNA structure from a user-defined DNA nucleotide sequence (in the 5 0 -3 0 direction). The generated DNA could be canonical DNA based on the parameters adopted from fiber diffraction studies or MD DNA based on the average parameters obtained from molecular dynamics simulations. This step also generates a parameter file containing the information on six base-pair (XY) and six base-pair step (XpY) parameters retrieved using-'Fiber', 'find_pair' and 'analyze' modules of 3DNA software suite (Lavery and Sklenar, 1988; Lu and Olson, 2003) .
Step (ii). Biologically, an intercalation site creation is the result of DNA unwinding with huge conformational changes occurring at adjacent base-base stacking and sugar phosphate backbones in order to accommodate an intercalator which is followed by rewinding (Trieb et al., 2004) . Here, an intercalation site is created by modifying the geometrical parameters of the DNA structure generated in step (i) according to the reference library developed in-house. The reference library stores the basic rigid body parameters of the DNA having the intercalation site. The library is created by gathering known RCSB PDB structures with the intercalation site(s), analyzing their base-pair and base-pair step parameters using 3DNA software and averaging them to obtain standard parameter values-which could be used to unwind a regular DNA for creating an intercalation gap. The change in DNA backbone torsion angles from unbound to bound geometry are embedded implicitly in these base-pair and base-pair step parameters. In this step, all the existing parameters of the DNA (only at the local position where intercalation site needs to be generated) are substituted by the library parameters for the local base-pairs (bp) and base-pair steps (without influencing the global DNA structure). Table 1 lists the set of reference library parameters prepared in this study, where bp_1 and bp_2 refer to the upper and lower base-pairs of an intercalation site.
Step (iii). This final step involves the regeneration of DNA 3D structure with an intercalation site using the above library parameters. The parameter file modified at the previous step (local position) is used here for the recreation of DNA structure (canonical or MD DNA) by utilizing 'rebuild' module of 3DNA software (Lu and Olson, 2003) which eventually results in the creation of a DNA with an intercalation site. One may use steps (ii) and (iii) multiple times to create a DNA structure with multiple intercalation sites.
This algorithm of generating DNA structure with an intercalation site is useful in the absence of crystal structures of DNA having preformed intercalation site(s). Therefore, a simple methodology for DNA with an intercalation site is provided by Intercalate without modifying DNA manually or by forceful insertion of intercalator molecule in a regular piece of DNA at a particular position, followed by energy minimization (EM) & molecular dynamics (MD) simulations to transform it to a regular intercalation site.
Dataset preparation
A large dataset of 102 DNA-intercalator complexes is collected and divided into two groups based on the availability of structures and energetics. The dataset contains various examples of DNA-intercalator complexes, which is devoid of many redundancies and Hoogsteen base pairing. Complexes with known experimental structures (65 in number) are used for docking and complexes with known binding energies (43 in number) are used for scoring studies. 6 complexes in the dataset are common with both known structures and energetics (65 þ 43 À 6 ¼ 102). For performing docking experiments, explicit hydrogens are added using leap module of AMBER14 to the 65 complexes taken from RCSB/NDB databases (Case et al., 2005) . AM1-BCC methodology is adopted for partial charge calculation of ligand and force field parameters are assigned to the ligand and DNA using 'GAFF' and modified 'ff99bsc0' force fields (Pérez et al., 2007; Wang et al., 2004 Wang et al., , 2006 . We refer to these dockings as RCSB DNA dockings. Additionally, we conducted docking experiments with the DNA generated using both canonical and MD average parameters (as mentioned above) which we refer to here as canonical BDNA and MD DNA dockings.
For scoring function development, MD DNA structures are generated for 43 complexes based on the DNA sequence and intercalation site information/preference extracted from literature (only some reports share information about the exact DNA sequence and the specificity of ligand at a particular site (eg. CpG versus GpC)). The ligand structures sketched with Marvin (www.chemaxon.com) are geometry optimized using HF/6-31G* basis set. These calculations are done using Gaussian09 suite (Frisch et al., 2009) . This is followed by docking using above preparations. Further, to obtain the most reliable structures among the top 10 docked complexes, MD simulations are performed on the top ranked structure for 50ns adopting ABC (Ascona B-DNA Consortium) protocols (Beveridge et al., 2004; Lavery et al., 2009; Pasi et al., 2014) . Details of MD simulations are provided in supporting information. Final structures of the complexes are extracted from the last coordinates of the stable RMSD trajectories from the production run and are used for scoring function development. For the 6 complexes with known structures and energetics, we compared the local RMSDs of the final structures with the crystal ones (values shown in Table S1 of supporting information). As the crystal structures have second intercalation site also, therefore only local RMSDs are calculated. The final MD structures agree well (average RMSD $ 1.5 Å ) with experimental structures.
Docking methodology
The docking engine deployed in Intercalate methodology is a modified version of ParDOCK which does rigid body docking by initially creating $0.2 million (M) configurations of the ligand (Gupta et al., 2007) . It uses a Monte Carlo search engine which efficiently samples the entire configurational space. Since majority of the naturally occurring intercalators (along with those included in the dataset) are characterized by the presence of planar aromatic rings with or without bulky substituents, the presence of aromatic chromophore is initially checked. The local reference frame at the DNA intercalation site is determined using 3DNA software, which is followed by an alignment of the ligand planar region in the xy plane (perpendicular to helical (z) axis) of the DNA reference frame. The best possible grid/translational points are identified by creating a grid of cube 6 Å 3 volume from centroid of the ligand. Now, a DNA grid of cube 10 Å 3 volume is created and a pre-calculation of the energy is done in and around the intercalation site of the DNA based on the 
Scoring methodology
Computationally, an accurate prediction of binding energy in DNA-ligand systems is rather complicated compared to proteinligand systems, as a large number of factors play a significant role in DNA-ligand binding particularly in intercalation mode. Mimicking DNA-ligand system requires careful attention of system's stability which is affected by solvent and counter-ion atmosphere. DNA is a highly charged molecule and unwinding/rewinding to intercalate i.e. structural deformation is expensive. Assembling a computational methodology for estimating binding energies requires a careful consideration of all these and more. Here, an energy function is proposed which can accurately predict the binding free energies of DNA-intercalator complexes. It is an extension of a previous scoring function developed for DNA-minor groove binders (Shaikh and Jayaram, 2007 
where DG cbe is the computed binding energy. Usually, minor groove binders interact with DNA without causing large structural perturbations whereas intercalators induce energetically highly unfavourable structural deformations in DNA by creating an intercalation site. DH def is a measure of the energy penalty required to create an intercalation site in a regular unbound DNA. We calculate the deformation energy of the DNA (including enthalpic and entropic terms) as the difference of the total energies for the regular DNA (without intercalation cavity) and deformed DNA (with intercalation cavity) utilizing the molecular mechanicsgeneralized born surface area (MM-GBSA) and normal-mode analysis (NMODE) methods of AMBER Still et al., 1990) . Both the DNAs, regular and deformed, are generated using MD parameters and are minimized for 2500 steps (1000SD þ 1500CG). During minimizations, the structures are in careful observation, as MD of the deformed DNA (without ligand) leads to a collapse of the intercalation gap turning it into a regular physiological DNA; however minimizations do not affect the structures largely and hence preferred. DH ele is the electrostatic contribution calculated using coulomb's law, employing a sigmoidal dielectric function for treating solvation electrostatics and scaled phosphate charges for treating counterion effects (Arora and Jayaram, 1998; Manning, 1978; Young et al., 1998) . DH vdw includes the direct van der Waals contributions calculated using Lennard-Jones potential and desolvation van der Waals calculated using solvent accessible surface area loss of DNA (Cornell et al., 1995; Jayaram et al., 1999) . TDS rt represents the entropic (translational and rotational) contributions upon formation of DNA-ligand complex and is calculated from ideal gas partition function Q (Jayaram et al., 1999; Soniat et al., 2016) . The vibrational/configurational entropy losses upon complex formation are neglected which demand further calculations and extension of the methodology. DG w is the energy associated with the rearrangement of water molecules upon ligand binding to DNA and is calculated using hydration heat capacity (Lane and Jenkins, 2000; Ren et al., 2000; Spolar et al., 1989) . A detailed description of each parameter (in Eq. 1) and the thermodynamic cycle adopted for computation of DNA-intercalator energy is provided in supporting information.
Results and discussions
3.1 Performance of Intercalate methodology on creating DNA structure with intercalation site(s)
Most of the complexes available in RCSB database (used in the docking dataset) have two intercalation sites with ligands bound to them. We attempted to create a similar MD DNA and canonical BDNA by providing the DNA sequence and intercalation site information (one or two) as mentioned in the database. Seven complexes in the dataset contain modified residues and are ignored for DNA generation. Surprisingly, the DNA structures generated with respective intercalation site(s) are consistent with the experimental structures with an average RMSD of 1.3 Å for MD DNA and 1.5 Å for canonical BDNA as shown in Figure 2 . MD DNA structures are found to be more accurate than the canonical BDNA structures in all the cases (Figs 2 and 3) . Additional details are provided in supplementary (Supplementary Table S2 ).
Performance of Intercalate methodology on docking experiments
An initial set of docking experiments is performed on RCSB DNA structures (65 complexes) having preformed intercalation site(s). Docking is performed at only one intercalation site and the results are compared with the standard RCSB structures to assess the efficiency of docking protocol. For a better comparison, the crystal information of second ligand is removed from the RCSB complexes. Two RMSD criteria are adopted, one for the top structure from docking and the other for the best structure (relative to crystal) in the top 10 docked poses. Among the top ranked structures, 85% of the cases have an RMSD < 2.0 Å whereas for the best structure, 95% of the cases fall under 2.0 Å RMSD criterion. Docking reported by Gilad et al. (Gilad and Senderowitz, 2014) on a large dataset of RCSB complexes using AUTODOCK has an accuracy of 75% for the top ranked and 84% for the best structure with an RMSD criterion of <2.0 Å . Table 2 . Again, MD DNA dockings are better than canonical BDNA dockings which is due to higher accuracy in generating DNA models. Additional details of these docking experiments are provided in supporting information (Supplementary Table S3 ).
To have a closer/magnified look at the docking accuracies while ignoring the errors due to DNA structures, RMSDs are recalculated for each case using a 5 Å distance cut-off criterion from the centroid of the ligand considered. In essence only 4 neighbouring nucleotides are selected as reference frame for the ligand (local) RMSD calculations. The best structure leads to docking accuracies of 88%, 83% and 72% (refer to Table 2 for cut-offs to calculate percentages) which correspond to RCSB DNA, MD DNA and canonical BDNA dockings (Fig. 4A) , which is also higher than those reported previously. It is expected that the accuracies will improve further upon MD simulations on the complexes. The RMSDs of only ligands for the best structures are also provided (Fig. 4B) .
The performance of docking via Intercalate methodology is demonstrated with the help of an example of ellipticine bound to CGATCG (1Z3F) and epirubicin bound to TGTACA sequence (1D54) (Fig. 5) . Ellipticine is an antineoplastic agent and epirubicin is an FDA approved drug used as a chemotherapeutic agent in the treatment of breast cancer. Epirubicin is favoured over its parent precursor doxorubicin, differing in the spatial arrangement of hydroxyl group linked to 4 0 -carbon of deoxyribose sugar (Bonfante et al., 1980; Demain and Sanchez, 2009 ). The docking accuracies of Intercalate methodology of course depend upon the type of DNA structure (crystal/RCSB or MD or canonical). Better is the DNA structure, better is the docking result.
Performance of Intercalate methodology on binding energy estimations
A swift all-atom energy based function is proposed for an efficient prediction of ligand binding energetics. The final structures of all the 43 complexes served as input to devise the final scoring equation as Eq. 2. Multiple linear regression is utilized for estimating the DNA-intercalator binding free energies and for obtaining the coefficients in Eq. 2. We also tried picking the average structure from the stable trajectories. The correlation coefficient (R) drops to 0.77. However when any random structure is picked from the stable trajectories, the R value rises again. This could be due to averaging which results in an artificial structure whereas the single structure from the trajectory is the actual Newtonian representative of the molecule and hence final structures are chosen.
Here, DG pred is the predicted binding free energy, DH def is the deformation energy, DH ele is the electrostatic energy, DH vdw is the van der Waals energy, TDS rt is the entropy contribution and DG w is the hydration energy. Regression yielded a correlation coefficient (R) of $0.83 with standard error of 0.5 kcal/mol between the predicted and experimental binding energies (Fig. 6) . The methodology is confined to the binding of planar intercalators to oligonucleotides binding non-covalently. Results of Intercalate scoring function are provided in supporting information (Supplementary Table S4 ). The difference in the scoring energy for the correct versus incorrect orientations of the ligand at the actual reference frame of the DNA (obtained from available crystal structures) is in the range of $0.5 to 2 kcal/mol; however, the energies could differ further based on various translational points.
The high correlation observed between experimental and predicted binding free energies indicates the overall system's stability and the practicality of the function adopted. The various energetic components, DH def , DH ele , DH vdw , DG w and TDS rt -all set to play a predictive role-are observed to be of high statistical significance. Contributions from van der Waals and cavitation/hydrophobicity are highly favourable. As expected, the changes in rotational and translational entropy are highly unfavourable due to entropy loss upon complex formation. Reordering of water molecules around the complex compensates for the entropy loss and thus contributes favourably. Deformation is a penalty and thus contributes unfavourably. While considering each term individually, the observed correlations are DH
The results are in total conformity with experiment which underscores the importance of van der Waals and hydrophobicity in drug-DNA intercalation process (Qu and Chaires, 2001; Schwaller et al., 1991) .
Further, the DNA backbone torsion angles (alpha, beta, gamma, delta, epsilon, zeta and chi (defined in supplementary) ) at the intercalation position are examined to observe the deviations between the regular DNA and deformed DNA. Final structures of the regular DNA extracted from the MD production runs are used as the standard torsional parameters and the final structures of the deformed DNA extracted from the scoring and docking datasets are used to examine the deviations. The most prominent deviations are noticed on delta, epsilon and zeta torsional angles and with a small effect on other torsions. All the backbone torsion angles of the regular DNA and the deformed DNA are provided in Table S5 and S6 of the supporting information. Additionally, the helical (base-pair step) parameters of the DNA for all the complexes are provided in Table S7 of the supporting information.
Free energy analyses of DNA-intercalation complexes
A free energy analysis is also performed on 43 complexes to further identify the dominant energetic contributors driving the DNA-intercalation process. Both MM-GBSA and MM-PBSA methodologies are employed for a detailed free energy analysis. A large dataset is again used for the thermodynamic analysis of drug-DNA intercalation complexes, which would strengthen our scoring function prediction in the context of favourable and unfavourable energy contributions. Thermodynamic analyses for DNA-intercalators is different from the DNA-minor groove, and protein-ligand complexes, as it involves a huge structural deformation in DNA for the creation of an intercalation gap.
The free energy estimation of drug intercalation requires DNA unwinding and binding energetics. For estimating DNA unwinding contribution, another set of 50ns MD simulations are performed on initially generated regular DNA (without the intercalation gap). MM-GB/PBSA and NMODE modules are used for calculating the unwinding energy (DG unwind) and binding energy (DG bind).
DNA unwinding is calculated as the difference between the intramolecular contributions (enthalpy and entropy) of an initial regular DNA and final deformed DNA (Rohs and Sklenar, 2001 ). The individual deformed DNA energies are extracted from the complex energies. Besides, the binding energy comprises gas phase molecular mechanics energy intrinsic to the molecule (DG gas) including the non-bonded electrostatics (DG ele) and van der Waals (DG vdW)
contributions and solvation free energy (DG solv) including the polar and non-polar contributions to solvation. The polar/electrostatic contribution to solvation (DG solv,pol) is calculated using GB and PB model. The non-polar part of solvation energy (DG solv,npol) is based on solvent-accessible surface area (SASA)
which is determined as c*SASA (c is the surface tension). The nonpolar solvation energy is due to van der Waals interactions between the solute and solvent (cvdW) and cavitation term (ccav) (energy required in alteration of cavity in solvent from initial to final states). The c is commonly set as 0.0072 kcal/mol Å 2 in GB/PBSA calculations, which is the resultant of À0.0398 kcal/mol Å 2 and 0.047 kcal/ mol Å 2 corresponding to vdW and cavitation terms respectively. MM-GB/PBSA calculations are performed on 50 frames picked at every 400ps from the last 20ns trajectory of the production run.
The entropy (DG trv) calculations are performed using NMODE which includes the translational, rotational and vibrational entropies. Entropy calculations are also performed on the same 50 frames chosen for MM-GB/PBSA studies.
Thus, net energy is the resultant of deformation, electrostatics, van der Waals, solvation and entropy components as represented in Figure 7 . Direct electrostatics, direct vdW and cavitation contribute favourably whereas the electrostatics and vdW component of solvation along with entropy and deformation contribute unfavourably (Fig. 7A) . Figure 7B containing the net energetics emphasizes vdW and hydrophobicity to be the most favourable contributors to binding free energy. Overall, the thermodynamic analyses correlate well with the predicted analysis and experimental energies, indicating the reliability of the designed energy function.
Conclusions
We describe here a state-of-the-art, robust and dedicated drug-DNA intercalation methodology for an efficient prediction of drug binding pose and its associated binding free energy using a large dataset fetched from public repositories and literature. Intercalate methodology holds the potential for the identification of new ligand molecules intercalating to DNA non-covalently. A webserver is also created based on the proposed methodology and is made freely accessible (www.scfbio-iitd.res.in/intercalate). The webserver contains both the datasets, all the structures used in developing the methodology and a guide to its usage. The conclusive highlights of our work include:
• Automated methodology for the creation of accurate DNA structures with a desired intercalation site from the DNA sequence and intercalation site information using MD DNA and canonical BDNA parameters is reported. The structures generated using MD DNA are better than the canonical BDNA.
• Docking experiments performed with Intercalate methodology on RCSB DNA, MD DNA and canonical BDNA structures reveal high levels of accuracies with each model in predicting the best binding pose of an intercalator at the DNA intercalation site considering various binding modes-classic/mono-intercalation, threading intercalation, parallel and perpendicular intercalation. Accuracies are higher in the order of RCSB DNA > MD DNA > canonical BDNA.
• A scoring function is developed comprising contributions from deformation, electrostatics, van der Waals, entropy and hydration energies which achieves a good correlation with the experimental binding energies. • Free energy analyses of the complexes highlight the dominant contributions from van der Waals and hydrophobicity terms, underscoring the importance of both enthalpy and entropy in the drug-DNA intercalation process.
